tirzepatide uric acid levels study Comparative Efficacy and Safety of in Asians and Non-Asians with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis | Diabetes Therapy The promise of tirzepatide: A

This work was funded by foundation grant 154321 from the Canadian Institutes of Health Research to DJD

Here are the results that shaped global policy: STEP 1 Trial (Wilding et al., 2021) 1,961 adults without diabetes Received 2.4 mg semaglutide weekly for 68 weeks Average weight loss: 14.9% of body weight Placebo group: 2.4% STEP 2 Trial (Davies et al., 2021) Focused on adults with type 2 diabetes The semaglutide group lost 9.6% of body weight STEP 3 & 4 Trials Evaluated behavioural therapy and long-term maintenance Confirmed semaglutides ability to prevent weight regain STEP 8 Trial (Rubino et al., 2021) Compared semaglutide with liraglutide (Saxenda) Semaglutide resulted in almost double the weight loss What to Expect When Starting Ozempic for Weight Loss When starting Ozempic (or any semaglutide-based medication), the initial weeks are focused on dose titration, gradually increasing the dose to allow the body to adjust and minimise side effects

Participants who had already lost at least 5% of body weight on a low-calorie diet were randomized to liraglutide or placebo

As with any medication for chronic conditions, maintenance is part of the protocol